| Tag | Content |
|---|
EnhancerAtlas ID | HS019-10822 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr22:24145740-24146640 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXH1 | MA0479.1 | chr22:24145786-24145797 | TGTGGATTGGG | - | 6.14 | | HNF4G | MA0484.1 | chr22:24145801-24145816 | TGAACTTTGGACTCT | - | 8.33 | | KLF4 | MA0039.3 | chr22:24145740-24145751 | GGAGGGTGTGG | - | 6.32 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_11313 | chr22:24140042-24150111 | CD20 | | SE_58708 | chr22:24131220-24192441 | Ly1 | | SE_59487 | chr22:24131152-24150045 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I023799 | chr22 | 24142164 | 24146113 |
|
Enhancer Sequence | GGAGGGTGTG GGCTCTGGGT TCAGTCCTGG TTCTGTTGCT GTTCACTGTG GATTGGGCCT 60
GTGAACTTTG GACTCTTTCC CCATACTGAG GTTGGGTGGC CCAAGAGGCC TGGCATGGGA 120
GGCGGCTGAT CTGCATAGCA TGGATGATGA TGACAATGCC AGTCAGACCT AGTTCAGCCC 180
CCGAGCCCTG CACACACCTG CCTTGGGTCC TGTCCACCAC TCTGCTTCTG CTGTGTGAGG 240
CTGCATGTGT GCCCCGTGCC TCTCTCCTCC TCTAACTGGT CATCTCTAGA CATCCTCACT 300
CTGTAAGTCC TGGGTCAGAT GCCATCTCTT CTGGCTCTTC CTGGGCTTCC AAAGCCTGGA 360
CAGAACTCGG TCTTTGTGCA AATGTAGACA GAAAGGTTAG AAGGATATGC ATCCCAGGTG 420
TCTAGACTGC TTATCCCATC TGGGAGGGTG GATCATGCAT GCATTTATTG TTTTCTCTAT 480
TTTTAAGTCT GTTAGAATGT ATTTTTATTA TTTTATTTTA TGATTACTGT TTTTTTAGAT 540
CTTGTTGCAT ACCAGTTTTT TTTTTACTTA GTGTCTGTAT CCTGCTGAAT TTTTATAATG 600
AACATACTAT TTATATTCAG ACAAAATGCA GTGAATATCA TCTTTATTTT ACTTATTTTT 660
TTTTTTAAGA GACAGAGTCC CACTCTGTTG CCCAGGCTGG AGTACAGTGA TACTCTCATA 720
GCTCACTGTA ATCTTGAACT GCCTGGGCTC AAGCAGTCCT CCTGCCACAG CCTCCCAAAT 780
AGCTAGGAAT ACAGGTGTGC ACCACTGTGC CAAGCGTTAC CATTTTTAAA TGAGTAAATG 840
TTTAAAATCA TCAGAATCTC ACCACCTGAA TAATGTTTTC AGTTTTACCT TTTCTGTCAA 900
|
